|
|
|
|
Malignant Pleural Mesothelioma
Kenneth O'Byrne and Valerie Rusch
474 pages
|
Illustrated in full colour throughout
|
246x171mm
978-0-19-852930-9
|
Hardback
|
16 November 2006
|
|
This item is printed to order and supplied on a firm sale basis. Items which are printed to order are normally despatched and charged within 5-10 days.
|
|
|
- This book is extremely timely given the increasing importance and prevalence of the disease
- The instance of malignant pleural mesothelioma is not expected to reach its peak until 2020 so a comprehensive, evidence-based book on the subject is needed
- Mesothelioma is an active area of research as physicians are becoming more aware of the problem
Malignant pleural mesothelioma, a malignancy due largely to asbestos exposure, represents an increasingly common challenge to clinical and medical oncologists, respiratory physicians, and cardiothoracic surgeons, as well as researchers in the field. The disease has yet to reach its peak and is expected to kill over 100,000 people worldwide. As malignant pleural mesothelioma gains in profile, Kenneth O'Byrne and Valerie Rusch present a comprehensive overview of the subject, aimed at all health care professionals who come into contact with patients with the disease.
The book includes chapters on
epidemiology, diagnosis, histopathology, radiology, surgery, chemotherapy, immune therapy, radiotherapy, and palliative medicine, written by an international team of contributors. A molecular biology section focuses on the carcinogenic effects of asbestos fibres and simian virus 40, angiogenesis and angiogenic growth factors, the immune response, and genetic abnormalities detected in the disease. Future therapies are also covered, as is a perspective on the distinct legal issues related to the disease. This highly-illustrated, full colour book provides the ultimate, timely resource on this devastating disease.
Readership: Aimed at clinical and medical oncologists, respiratory physicians, and
cardiothoracic surgeons; palliative care physicians and specialist nurses will also be interested as well as researchers.
|
|
|
Kenneth O'Byrne, Consultant Oncologist, Hope Directorate, St James's Hospital, Dublin, Ireland, and Valerie Rusch, Chief of the Thoracic Service Surgery, William G Cahan Chair, Memorial Sloan-Kettering Cancer Center, New York, USA Contributors:
Raymond P Abratt, Professor of Radiation Oncology, University of Cape Town, South Africa
Deborah A. Altomare, Staff Scientist, Human Genetics Program, Fox Chase Cancer Center, Philadelphia, USA
Paul Baas, Consultant Thoracic Oncologist, Netherlands Cancer Institute, Amsterdam, The Netherlands
Sofia Baka, Department of Medical Oncology, Christie Hospital
NHS Trust, Manchester, UK
Izzettin Baris, Emeritus Professor of Chest Medicine, Guven Hospital Medical Center, Kavaklidere, Ankara, Turkey
Fiona Blackhall, Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK
Maurizio Bocchetta, Research Assistant Professor, Department of Pathology and Oncology Institute, Loyola University, Cardinal Bernardin Cancer Center, Maywood, USA
Daniel J Boffa, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
S Broomfield, Research Scientist, University of Western Australia, School of Medicine and Pharmacology, QEII Medical Centre, Perth, Australia
Adrian Budgeon
J.A Burgers, Respiratory Physician, Department of Thoracic
Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Michele Carbone, Associate Professor of Pathology, Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, USA
Elzbieta Chyczewska, Department of Pneumonology, Academy of Bialystok, Poland
Lech Chyczewski, Department of Clinical Molecular Biology, Academy of Bialystok, Poland
Helen Clayson, Medical Director, St Mary's Hospice, Ulverston, Cumbria, UK
S Danson, Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK
Peter A DeLong, Assistant Professor, Dartmouth-Hitchcock Medical Center, Lebanon, USA
John Edwards, Department of Thoracic Surgery, Glenfield Hospital, Leicester,
UK
Salih Emri, Associate Professor of Medicine, University of Hacettepe, Medical Center, Ankara, Turkey
James Entwisle, Consultant Radiologist, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK
Kenneth M Forster, Assistant Professor, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Texas, USA
Françoise Galateau-Sallé, Department of Pathology, University of Caen, Caen, France
Steven Gray, Lecturer and Clinical Scientist, Trinity College Institute of Molecular Medicine, St James' Hospital, Dublin, Ireland
Philip S Hasleton, Department of Pathology, South Manchester University Hospital Trust, Manchester, UK
J.P.J.J Hegmans, Erasmus MC, Department of
Pulmonology, Rotterdam, The Netherlands
C Jackaman, University of Western Australia, Perth, Australia
Juliet E King, Department of Thoracic Surgery, Birmingham Heartlands Hospital, Birmingham, UK
NH de Klerk, Adjunct Professor, Institute for Child Health Research, University of Western Australia, Western Australia
B Koloska, Research Assistant, Tumour Immunology Group, University of Western Australia, Perth, Australia
S Lansley, Asthma Allergy Research Institute, University of Western Australia, Perth, Australia
Jerzy Laudanski, Department of Thoracic Surgery, Academy of Bialystok, Poland
John Ned Lipsitz, Attorney at Law, Buffalo, New York, USA
Antonio E. Martin-Ucar, Department of Thoracic Surgery,
Glenfield Hospital, Leicester, UK
Brooke T Mossman, University of Vermont, Department of Pathology, Burlington, USA
AW Musk, Clinical Professor of Medicine and Public Health, University of Western Australia; Consultant Physician, Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia
Wojciech Naumnik, Department of Pneumonology, Academy of Bialystok, Poland
D.J Nelson, Research Fellow, Curtin University, Perth, Australia
Wieslawa Niklinska, Department of Histology & Embryology, Academy of Bialystok, Poland
Jacek Niklinski, Department of Thoracic Surgery, Academy of Bialystok, Poland
Mary ER O'Brien, Consultant Medical Oncologist, Royal Marsden Hospital, Sutton, UK
Kenneth J O'Byrne, Consultant Oncologist, Hope Directorate, St James's Hospital, Dublin, Ireland
Michael D Peake, Consultant Physician and Honorary Lecturer in Respiratory Medicine, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester UK
Eric Pluygers, Department of Oncology, Jolimont Hospital, La Louviere, Belgium
Amy Powers, Resident Physician, Cleveland Clinic Foundation, Department of Pathology, Cleveland, USA
Malcolm Ranson, Senior Lecturer in Medical Oncology, University of Manchester, Manchester, UK
Ander Urruticoechea Ribate, Medical Oncologist, Institut Catalé d'Oncologie, Hospital Duran i Reynals, Barcelona, Spain
Bruce Robinson, Professor of Medicine, Chest Physician, University of
Western Australia, School of Medicine and Pharmacology, Sir Charles Gairdner Hospital, Nedlands, Australia
Robin M Rudd, Consultant Physician, Department of Medical Oncology, St Bartholomew's Hospital, London, UK
Valerie W Rusch, Chief, Thoracic Surgery, Memorial Sloan-Kettering Cancer Center; Professor of Surgery, Cornell University Medical College, New York, USA
Roberto Salgado, Department of Pathology, Translational Cancer Research Group, University Hospital, Antwerp, Belgium
AM Smith, University of Western Australia, Perth, Australia
W. Roy Smythe, Professor & Chairman, Department of Surgery, Texas A & M University College of Medicine, Scott & White Hospital, Temple, Texas, USA
Bernard Souberbielle, Medical Adviser,
Schering Healthcare Ltd, Burgess Hill, UK
Jeremy P.C Steele, Consultant Medical Oncologist, Mesothelioma Unit, St Bartholomew's Hospital, London, UK
Daniel H Sterman, Assistant Professor of Medicine, Director, Interventional Pulmonology Clinical Director, Thoracic Oncology Gene Therapy Program, Pennsylvania, USA
Craig W Stevens, Associate Professor of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA
William Swain, Department of Oncology, Glenfield Hospital, Leicester, UK
Joseph R Testa, Director, Human Genetics Program, Fax Chase Cancer Center, Philadelphia, USA
Murat Tuncer, Director of the National Cancer Control Department, Ministry of Health, Ankara, Turkey
Eric A Van Marck,
Professor of Pathology, University of Antwerp, Antwerp, Belgium
Peter B Vermeulen, Surgical Pathologist, General Hospital Sint-Augustinus, Antwerp, Belgium
Daniel A Vorobiof, Director, Medical Oncology, Sandton Oncology Centre, Johannesburg, South Africa
David Waller, Honorary Senior Lecturer in Medicine & Surgery, Leicester Warwick Medical School; Consultant Thoracic Surgeon, Glenfield Hospital, Leicester, UK
Neil White (deceased)
Uwe Zangemeister-Wittke, Department of Oncology, University Hospital Zurich, Switzerland
|
|
|
"...this book is one of the best. ...Anybody dealing with diffuse malignant mesothelioma, in either a research or clinical setting, should learn a great deal from this book in topics outside his or her own immediate specializations." - Respiratory Care, Vol 52, No 8,
|
|
|
Section 1. Clinical Features of Mesothelioma
1: Juliet E King & Philip S Hasleton: The Epidemiology and Aetiology of Malignant Mesothelioma
2: AW Musk, NH de Klerk, Jacek Niklinski, Wieslawa Niklinska, Elzbieta Chyczewska, Jerzy Laudanski, Wojciech Naumnik, Lech Chyczewski, Eric Pluygers, Raymond P Abratt, Daniel A Vorobiof, Neil White, Salih Emri, Murat Tuncer & Izzettin Baris: Epidemiological Snapshots From Around the World
3: Michael D Peake & James Entwisle & Steven Gray: Clinical Presentation, Radiological Evaluation and Diagnosis
4: Juliet King, Françoise Galateau-Sallé & Philip Hasleton: Histopathology of Malignant Pleural Mesothelioma
5: J.A Burgers & J.P.J.J Hegmans: Clinico-Pathological Prognostic Factors & Scoring Systems in Malignant Pleural Mesothelioma
Section 2. Biology of Mesothelioma
6: BT Mossman & William Swain: Carcinogenic Mechanisms in Mesothelioma: Effects of asbestos on cell signal events, transcription factors, and inflammatory cytokines
7: Amy Powers, Maurizio Bocchetta & Michele Carbone: Viral Factors in the Pathogenesis of Malignant Mesothelioma
8: John G Edwards, Uwe Zangemeister-Wittke & Kenneth J O'Byrne: Growth Factors, Cyclooxygenease-2 and Matrix Metalloproteinases in Malignant Mesothelioma
9: Peter B Vermeulen, Roberto Salgado & Eric A Van Marck: Vascularisation in Malignant Mesothelioma
10: AM Smith, S Lansley, C Jackaman, B Koloska, S Broomfield, Bruce W.S Robinson & D.J Nelson: Immunobiology of Malignant Mesothelioma
11: Deborah A Altomare & Joseph R Testa: Cytogenetic and Molecular Genetic Changes in Malignant Mesothelioma
Section 3. Treatment Strategies
12: David A Waller & Antonio E Martin-Ucar: The Role of Surgery for Diagnosis, Staging and Symptom Control in Malignant Pleural Mesothelioma
13: Daniel J Boffa & Valerie W Rusch: Surgical and Multimodality Approaches to the Management of Operable Malignant Mesothelioma
14: Jeremy P.C Steele & Robin M Rudd: Systemic Chemotherapy for Malignant Pleural Mesothelioma
15: Craig W Stevens, Kenneth M Forster & W. Roy Smythe: Radiotherapy for Mesothelioma
16: Mary ER O'Brien, Ander Urruticoechea Ribate & Bernard Souberbielle: Immunotherapy for Malignant Mesothelioma
17: Paul Baas: Intra-thoracic Photodynamic Diagnosis and Treatment with Photodynamic Therapy or Hyperthermia of Malignant Mesothelioma
18: Fiona Blackhall, Sofia Baka, Sarah Danson and Malcolm Ranson: Novel Therapies for Mesothelioma
19: Daniel H Sterman & Peter A DeLong: Gene Therapy for Malignant Pleural Mesothelioma
20: Sam Ahmedzai & Helen Clayson: Palliative Care for Mesothelioma
21: Adrian Budgeon & John Ned Lipsitz: The Treatment of Mesothelioma Cases in the American and United Kingdom Legal Systems
|
|
|
|
|
|
|
|
|
Recently Viewed
|
|
|
|
The First Tractarian Bishop
Rowan Strong
£84.00
|
|
|
|
|
Luigi Ambrosio, Paolo Tilli
£49.00
|
|
|
|
|
Clifford A. Pickover
£15.00
|
|
|
|
|
The specification in this catalogue, including without limitation price, format, extent, number of illustrations, and month of publication, was as accurate as possible at the time the catalogue was compiled. Occasionally, due to the nature of some contractual restrictions, we are unable to ship a specific product to a particular territory. Jacket images are provisional and liable to change before publication.
|
|
